The Translational Regenerative Medicine Market Report 2024-2034: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.
Rising Chronic Diseases Driving Industry Growth
The global landscape of healthcare is witnessing a paradigm shift driven by the escalating prevalence of chronic diseases. Conditions such as cardiovascular diseases, diabetes, neurodegenerative disorders, and autoimmune diseases pose a significant burden on healthcare systems worldwide. In response to this growing health crisis, the field of Translational regenerative medicine (TRM) has emerged as a beacon of hope, offering innovative solutions to address the root causes of these chronic ailments. Translational regenerative medicine focuses on harnessing the body’s innate regenerative capabilities to repair, replace, or regenerate damaged tissues and organs. Stem cell therapies, tissue engineering, and other regenerative approaches hold the potential to revolutionize the treatment landscape for chronic diseases by addressing the underlying causes rather than merely managing symptoms. Translational regenerative medicine allows for the development of personalized therapies tailored to individual patient needs. This approach is particularly relevant in the context of chronic diseases where heterogeneity in patient responses is common. Advances in stem cell research, including the use of induced pluripotent stem cells (iPSCs) and adult stem cells, offer a diverse range of regenerative possibilities. Stem cell-based therapies hold promise for conditions such as diabetes, where the replacement of damaged pancreatic cells could restore normal insulin production.
High Development Costs Associated with Translational Regenerative Medicine
The initial phases of developing translational regenerative medicine therapies involve extensive research to understand the underlying biology and mechanisms. This early-stage research requires funding for laboratory equipment, personnel, and consumables. Clinical trials represent a major portion of the development costs. These trials are essential for evaluating the safety and efficacy of regenerative therapies in human subjects. Costs include patient recruitment, monitoring, regulatory compliance, and data analysis, all of which demand substantial financial resources. Transitioning from laboratory-scale production to large-scale manufacturing presents unique challenges. Ensuring the reproducibility, quality, and safety of regenerative therapies on a larger scale requires investment in manufacturing infrastructure and process optimization. Successfully bringing a regenerative medicine product to market is just the beginning. Companies face additional costs related to market access, including marketing, distribution, and post-marketing surveillance. These activities are crucial for ensuring widespread adoption and continued success.
What Questions Should You Ask before Buying a Market Research Report?
- How is the Translational Regenerative Medicine Market evolving?
- What is driving and restraining the Translational Regenerative Medicine Market?
- How will each Translational Regenerative Medicine submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2034?
- How will the market shares for each Translational Regenerative Medicine submarket develop from 2024 to 2034?
- What will be the main driver for the overall market from 2024 to 2034?
- Will leading Translational Regenerative Medicine Markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
- How will the market shares of the national markets change by 2034 and which geographical region will lead the market in 2034?
- Who are the leading players and what are their prospects over the forecast period?
- What are the Translational Regenerative Medicine projects for these leading companies?
- How will the industry evolve during the period between 2024 and 2034? What are the implications of Translational
- Regenerative Medicine projects taking place now and over the next 10 years?
- Is there a greater need for product commercialisation to further scale the Translational Regenerative Medicine Market?
- Where is the Translational Regenerative Medicine Market heading and how can you ensure you are at the forefront of the market?
- What are the best investment options for new product and service lines?
- What are the key prospects for moving companies into a new growth path and C-suite?
You need to discover how this will impact the Translational Regenerative Medicine Market today, and over the next 10 years:
- Our 270-page report provides 104 tables and 144 charts/graphs exclusively to you.
- The report highlights key lucrative areas in the industry so you can target them – NOW.
- It contains in-depth analysis of global, regional and national sales and growth.
- It highlights for you the key successful trends, changes and revenue projections made by your competitors.
This report tells you TODAY how the Translational Regenerative Medicine Market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.
Forecasts to 2034 and other analyses reveal commercial prospects
- In addition to revenue forecasting to 2034, our new study provides you with recent results, growth rates, and market shares.
- You will find original analyses, with business outlooks and developments.
- Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), and recent developments.
This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, “V”, “L”, “W” and “U” are discussed in this report.
Segments Covered in the Report
By Product
- Stem Cell Therapy: Autologous, Allogenic
- Tissue Engineering: Scaffold, Hydrogels
- Gene Therapy
- Others
By Application
- Oncology
- Dermatology
- Musculoskeletal
- Neurology
- Cardiovascular
- Wound Healing
- Ophthalmology
- Others
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 17 leading national markets:
North America
Europe
- Germany
- UK
- France
- Spain
- Italy
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia Pacific
Latin America
- Brazil
- Mexico
- Rest of Latin America
MEA
- GCC
- South Africa
- Rest of MEA
Need industry data? Please contact us today.
The report also includes profiles and for some of the leading companies in the Translational Regenerative Medicine Market 2024 to 2034, with a focus on this segment of these companies’ operations.
Leading companies profiled in the report
- Amgen Inc.
- Anterogen Co., Ltd.
- AVITA Medical, Inc.
- Biosolutions Ltd.
- bluebird bio, Inc.
- Bristol-Myers Squibb Company
- Gilead Sciences, Inc.
- Integra LifeSciences
- Mesoblast Ltd.
- Novartis AG
- Organogenesis Inc.
- Sarepta Therapeutics, Inc.
- Smith+Nephew
- TERUMO BCT, INC.
Overall world revenue for Translational Regenerative Medicine Market, 2024 to 2034 in terms of value the market will surpass US$77.0 billion in 2024, our work calculates. We predict strong revenue growth through to 2034. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How will the Translational Regenerative Medicine Market 2024 to 2034 report help you?
In summary, our 270-page report provides you with the following knowledge:
- Revenue forecasts to 2034 for Translational Regenerative Medicine Market 2024 to 2034, with forecasts for product and application each forecasted at a global and regional level – discover the industry’s prospects, finding the most lucrative places for investments and revenues.
- Revenue forecasts to 2034 for five regional and 20 key national markets – See forecasts for the Translational Regenerative Medicine Market, 2024 to 2034 in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
- Prospects for established firms and those seeking to enter the market – including company profiles for 14 of the major companies involved in the Translational Regenerative Medicine Market, 2024 to 2034.
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.
Information found nowhere else
With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the Translational Regenerative Medicine Market 2024 to 2034, market-leading companies. You will find data, trends and predictions.
To access the data contained in this document please email contactus@visiongain.com
Buy our report today Translational Regenerative Medicine Market Report 2024-2034: Forecasts by Product (Stem Cell Therapy (Autologous, Allogenic), Tissue Engineering (Scaffold, Hydrogels), Gene Therapy, Others)), by Application (Oncology, Dermatology, Musculoskeletal, Neurology, Cardiovascular, Wound Healing, Ophthalmology, Others) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Impact and Recovery Pattern Analysis. Avoid missing out by staying informed – order our report now.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: contactus@visiongain.com
1 Report Overview
1.1 Objectives of the Study
1.2 Introduction to Translational Regenerative Medicine Market
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered by This Analytical Report
1.6 Who is This Report for?
1.7 Methodology
1.7.1 Market Definitions
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Data Validation
1.7.3.1 Primary Research
1.7.3.2 Secondary Research
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Visiongain Reports
1.10 About Visiongain
2 Executive Summary
3 Market Overview
3.1 Key Findings
3.2 Market Dynamics
3.2.1 Market Driving Factors
3.2.1.1 Increasing Strategic Activities and Collaborations
3.2.1.2 Rise in Research and Development Projects
3.2.1.3 Surging Government Support
3.2.1.4 Growing Focus on Personalized Medicine
3.2.1.5 Emerging Applications in New Therapeutic Areas
3.2.1.6 Increasing Collaborations and Partnerships by Major Market Players
3.2.1.7 Increasing Regulatory Approvals in Regenerative Medicine
3.2.2 Market Restraining Factors
3.2.2.1 Substantial Number of Product Recalls
3.2.2.2 Unapproved Products in the Market
3.2.2.3 Reimbursement Policies
3.2.2.4 High Cost of Treatments
3.2.3 Market Opportunities
3.2.3.1 Growing Research Partnership in Developed and Developing Countries Across the Globe
3.2.3.2 Growing Awareness About the Advances in Medical Research
3.2.3.3 Growing Investment and Funding
3.2.3.4 Harnessing the Potential of 3D Printing
3.2.3.5 Integration with Artificial Intelligence and Big Data
3.2.3.6 Growing Number of Organ Transplants
3.3 COVID-19 Impact Analysis
3.4 Porter’s Five Forces Analysis
3.4.1 Bargaining Power of Suppliers
3.4.2 Bargaining Power of Buyers
3.4.3 Competitive Rivalry
3.4.4 Threat from Substitutes
3.4.5 Threat of New Entrants
3.5 PEST Analysis
4 Translational Regenerative Medicine Market Analysis by Product
4.1 Key Findings
4.2 Application Segment: Market Attractiveness Index
4.3 Translational Regenerative Medicine Market Size Estimation and Forecast by Product
4.4 Stem Cell Therapy
4.4.1 Translational Regenerative Medicine Market Size Estimation and Forecast by Stem Cell Therapy
4.4.2 Market Size by Region, 2024-2034 (US$ Billion)
4.4.3 Market Share by Region, 2024 & 2034 (%)
4.4.4 Autologous Stem Cell Therapy
4.4.4.1 Market Size by Region, 2024-2034 (US$ Billion)
4.4.4.2 Market Share by Region, 2024 & 2034 (%)
4.4.5 Allogenic
4.4.5.1 Market Size by Region, 2024-2034 (US$ Billion)
4.4.5.2 Market Share by Region, 2024 & 2034 (%)
4.5 Tissue Engineering
4.5.1 Translational Regenerative Medicine Market Size Estimation and Forecast by Tissue Engineering
4.5.2 Market Size by Region, 2024-2034 (US$ Billion)
4.5.3 Market Share by Region, 2024 & 2034 (%)
4.5.4 Scaffold
4.5.4.1 Market Size by Region, 2024-2034 (US$ Billion)
4.5.4.2 Market Share by Region, 2024 & 2034 (%)
4.5.5 Hydrogels
4.5.5.1 Market Size by Region, 2024-2034 (US$ Billion)
4.5.5.2 Market Share by Region, 2024 & 2034 (%)
4.6 Gene Therapy
4.6.1 Market Size by Region, 2024-2034 (US$ Billion)
4.6.2 Market Share by Region, 2024 & 2034 (%)
4.7 Others
4.7.1 Market Size by Region, 2024-2034 (US$ Billion)
4.7.2 Market Share by Region, 2024 & 2034 (%)
5 Translational Regenerative Medicine Market Analysis by Application
5.1 Key Findings
5.2 Application Segment: Market Attractiveness Index
5.3 Translational Regenerative Medicine Market Size Estimation and Forecast by Application
5.4 Oncology
5.4.1 Market Size by Region, 2024-2034 (US$ Billion)
5.4.2 Market Share by Region, 2024 & 2034 (%)
5.5 Dermatology
5.5.1 Market Size by Region, 2024-2034 (US$ Billion)
5.5.2 Market Share by Region, 2024 & 2034 (%)
5.6 Musculoskeletal
5.6.1 Market Size by Region, 2024-2034 (US$ Billion)
5.6.2 Market Share by Region, 2024 & 2034 (%)
5.7 Neurology
5.7.1 Market Size by Region, 2024-2034 (US$ Billion)
5.7.2 Market Share by Region, 2024 & 2034 (%)
5.8 Cardiovascular
5.8.1 Market Size by Region, 2024-2034 (US$ Billion)
5.8.2 Market Share by Region, 2024 & 2034 (%)
5.9 Wound Healing
5.9.1 Market Size by Region, 2024-2034 (US$ Billion)
5.9.2 Market Share by Region, 2024 & 2034 (%)
5.10 Ophthalmology
5.10.1 Market Size by Region, 2024-2034 (US$ Billion)
5.10.2 Market Share by Region, 2024 & 2034 (%)
5.11 Others
5.11.1 Market Size by Region, 2024-2034 (US$ Billion)
5.11.2 Market Share by Region, 2024 & 2034 (%)
6 Translational Regenerative Medicine Market Analysis by Region
6.1 Key Findings
6.2 Regional Market Size Estimation and Forecast
7 North America Translational Regenerative Medicine Market Analysis
7.1 Key Findings
7.2 North America Translational Regenerative Medicine Market Attractiveness Index
7.3 North America Translational Regenerative Medicine Market by Country, 2024, 2029 & 2034 (US$ Billion)
7.4 North America Translational Regenerative Medicine Market Size Estimation and Forecast by Country
7.5 North America Translational Regenerative Medicine Market Size Estimation and Forecast by Product
7.6 North America Translational Regenerative Medicine Market Size Estimation and Forecast by Application
7.7 U.S. Translational Regenerative Medicine Market Analysis
7.8 Canada Translational Regenerative Medicine Market Analysis
8 Europe Translational Regenerative Medicine Market Analysis
8.1 Key Findings
8.2 Europe Translational Regenerative Medicine Market Attractiveness Index
8.3 Europe Translational Regenerative Medicine Market by Country, 2024, 2029 & 2034 (US$ Billion)
8.4 Europe Translational Regenerative Medicine Market Size Estimation and Forecast by Country
8.5 Europe Translational Regenerative Medicine Market Size Estimation and Forecast by Product
8.6 Europe Translational Regenerative Medicine Market Size Estimation and Forecast by Application
8.7 Germany Translational Regenerative Medicine Market Analysis
8.8 France Translational Regenerative Medicine Market Analysis
8.9 UK Translational Regenerative Medicine Market Analysis
8.10 Italy Translational Regenerative Medicine Market Analysis
8.11 Spain Translational Regenerative Medicine Market Analysis
8.12 Russia Translational Regenerative Medicine Market Analysis
8.13 Rest of Europe Translational Regenerative Medicine Market Analysis
9 Asia Pacific Translational Regenerative Medicine Market Analysis
9.1 Key Findings
9.2 Asia Pacific Translational Regenerative Medicine Market Attractiveness Index
9.3 Asia Pacific Translational Regenerative Medicine Market by Country, 2024, 2029 & 2034 (US$ Billion)
9.4 Asia Pacific Translational Regenerative Medicine Market Size Estimation and Forecast by Country
9.5 Asia Pacific Translational Regenerative Medicine Market Size Estimation and Forecast by Product
9.6 Asia Pacific Translational Regenerative Medicine Market Size Estimation and Forecast by Application
9.7 Japan Translational Regenerative Medicine Market Analysis
9.8 China Translational Regenerative Medicine Market Analysis
9.9 India Translational Regenerative Medicine Market Analysis
9.10 Australia Translational Regenerative Medicine Market Analysis
9.11 South Korea Translational Regenerative Medicine Market Analysis
9.12 Rest of Asia Pacific Translational Regenerative Medicine Market Analysis
10 Latin America Translational Regenerative Medicine Market Analysis
10.1 Key Findings
10.2 Latin America Translational Regenerative Medicine Market Attractiveness Index
10.3 Latin America Translational Regenerative Medicine Market by Country, 2024, 2029 & 2034 (US$ Billion)
10.4 Latin America Translational Regenerative Medicine Market Size Estimation and Forecast by Country
10.5 Latin America Translational Regenerative Medicine Market Size Estimation and Forecast by Product
10.6 Latin America Translational Regenerative Medicine Market Size Estimation and Forecast by Application
10.7 Brazil Translational Regenerative Medicine Market Analysis
10.8 Mexico Translational Regenerative Medicine Market Analysis
10.9 Rest of Latin America Translational Regenerative Medicine Market Analysis
11 MEA Translational Regenerative Medicine Market Analysis
11.1 Key Findings
11.2 MEA Translational Regenerative Medicine Market Attractiveness Index
11.3 MEA Translational Regenerative Medicine Market by Country, 2024, 2029 & 2034 (US$ Billion)
11.4 MEA Translational Regenerative Medicine Market Size Estimation and Forecast by Country
11.5 MEA Translational Regenerative Medicine Market Size Estimation and Forecast by Product
11.6 MEA Translational Regenerative Medicine Market Size Estimation and Forecast by Application
11.7 GCC Translational Regenerative Medicine Market Analysis
11.8 South Africa Translational Regenerative Medicine Market Analysis
11.9 Rest of MEA Translational Regenerative Medicine Market Analysis
12 Company Profiles
12.1 Competitive Landscape, 2022
12.2 Strategic Outlook
12.3 Amgen Inc.
12.3.1 Company Snapshot
12.3.2 Company Overview
12.3.3 Financial Analysis
12.3.3.1 Net Revenue, 2017-2022
12.3.3.2 R&D, 2017-2022
12.3.3.3 Regional Market Shares, 2022
12.3.4 Product Benchmarking
12.3.5 Strategic Outlook
12.4 Anterogen Co., Ltd.
12.4.1 Company Snapshot
12.4.2 Company Overview
12.4.3 Product Benchmarking
12.5 AVITA Medical, Inc.
12.5.1 Company Snapshot
12.5.2 Company Overview
12.5.3 Financial Analysis
12.5.3.1 Net Revenue, 2017-2022
12.5.3.2 R&D, 2017-2022
12.5.4 Product Benchmarking
12.5.5 Strategic Outlook
12.6 Biosolutions Ltd.
12.6.1 Company Snapshot
12.6.2 Company Overview
12.6.3 Product Benchmarking
12.6.4 Strategic Outlook
12.7 bluebird bio, Inc.
12.7.1 Company Snapshot
12.7.2 Company Overview
12.7.3 Financial Analysis
12.7.3.1 Net Revenue, 2017-2022
12.7.3.2 R&D, 2017-2022
12.7.4 Product Benchmarking
12.7.5 Strategic Outlook
12.8 Bristol-Myers Squibb Company
12.8.1 Company Snapshot
12.8.2 Company Overviews
12.8.3 Financial Analysis
12.8.3.1 Net Revenue, 2017-2022
12.8.3.2 R&D, 2017-2022
12.8.3.3 Regional Market Shares, 2022
12.8.4 Product Benchmarking
12.8.5 Strategic Outlook
12.9 Gilead Sciences, Inc.
12.9.1 Company Snapshot
12.9.2 Company Overview
12.9.3 Financial Analysis
12.9.3.1 Net Revenue, 2017-2022
12.9.3.2 R&D, 2017-2022
12.9.3.3 Regional Market Shares, 2022
12.9.4 Product Benchmarking
12.9.5 Strategic Outlook
12.10 Integra LifeSciences
12.10.1 Company Snapshot
12.10.2 Company Overview
12.10.3 Financial Analysis
12.10.3.1 Net Revenue, 2017-2022
12.10.3.2 R&D, 2017-2022
12.10.3.3 Regional Market Shares, 2022
12.10.4 Product Benchmarking
12.10.5 Strategic Outlook
12.11 Mesoblast Ltd.
12.11.1 Company Snapshot
12.11.2 Company Overview
12.11.3 Financial Analysis
12.11.3.1 Net Revenue, 2017-2022
12.11.3.2 R&D, 2017-2022
12.11.4 Product Benchmarking
12.11.5 Strategic Outlook
12.12 Novartis AG
12.12.1 Company Snapshot
12.12.2 Company Overview
12.12.3 Financial Analysis
12.12.3.1 Net Revenue, 2017-2022
12.12.3.2 R&D, 2017-2022
12.12.3.3 Regional Market Shares, 2022
12.12.4 Product Benchmarking
12.12.5 Strategic Outlook
12.13 Organogenesis Inc.
12.13.1 Company Snapshot
12.13.2 Company Overview
12.13.3 Financial Analysis
12.13.3.1 Net Revenue, 2017-2022
12.13.3.2 R&D, 2017-2022
12.13.4 Product Benchmarking
12.13.5 Strategic Outlook
12.14 Sarepta Therapeutics, Inc.
12.14.1 Company Snapshot
12.14.2 Company Overview
12.14.3 Financial Analysis
12.14.3.1 Net Revenue, 2017-2022
12.14.3.2 R&D, 2017-2022
12.14.4 Product Benchmarking
12.14.5 Strategic Outlook
12.15 Smith+Nephew
12.15.1 Company Snapshot
12.15.2 Company Overview
12.15.3 Financial Analysis
12.15.3.1 Net Revenue, 2017-2022
12.15.3.2 R&D, 2017-2022
12.15.3.3 Regional Market Shares, 2022
12.15.4 Product Benchmarking
12.15.5 Strategic Outlook
12.16 TERUMO BCT, INC.
12.16.1 Company Snapshot
12.16.2 Company Overview
12.16.3 Financial Analysis
12.16.3.1 Net Revenue, 2017-2022
12.16.3.2 Regional Market Shares, 2021
12.16.4 Product Benchmarking
12.16.5 Strategic Outlook
13 Conclusion and Recommendations
13.1 Concluding Remarks from Visiongain
13.2 Recommendations for Market Players
List of Tables
Table 1 Translational Regenerative Medicine Market Snapshot, 2024 & 2034 (US$ Billion, CAGR %)
Table 2 Translational Regenerative Medicine Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%): “V” Shaped Recovery
Table 3 Translational Regenerative Medicine Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%): “U” Shaped Recovery
Table 4 Translational Regenerative Medicine Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%): “W” Shaped Recovery
Table 5 Translational Regenerative Medicine Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%): “L” Shaped Recovery
Table 6 Translational Regenerative Medicine Market Forecast by Product, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 7 Translational Regenerative Medicine Market Forecast by Stem Cell Therapy, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 8 Stem Cell Therapy Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 9 Autologous Stem Cell Therapy Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 10 Allogenic Stem Cell Therapy Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 11 Tissue Engineering Market Forecast by Stem Cell Therapy, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 12 Tissue Engineering Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 13 Scaffold Tissue Engineering Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 14 Hydrogels Tissue Engineering Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 15 Gene Therapy Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 16 Others Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 17 Translational Regenerative Medicine Market Forecast by Application, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 18 Oncology Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 19 Dermatology Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 20 Musculoskeletal Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 21 Neurology Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 22 Cardiovascular Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 23 Wound Healing Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 24 Ophthalmology Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 25 Others Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 26 Translational Regenerative Medicine Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 27 North America Translational Regenerative Medicine Market Forecast by Country, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 28 Translational Regenerative Medicine Market Forecast by Product, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 29 Translational Regenerative Medicine Market Forecast by Application, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 30 U.S. Translational Regenerative Medicine Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 31 Canada Translational Regenerative Medicine Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 32 Europe Translational Regenerative Medicine Market Forecast by Country, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 33 Translational Regenerative Medicine Market Forecast by Product, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 34 Translational Regenerative Medicine Market Forecast by Application, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 35 Germany Translational Regenerative Medicine Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 36 France Translational Regenerative Medicine Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 37 UK Translational Regenerative Medicine Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 38 Italy Translational Regenerative Medicine Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 39 Spain Translational Regenerative Medicine Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 40 Russia Translational Regenerative Medicine Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 41 Rest of Europe Translational Regenerative Medicine Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 42 Asia Pacific Translational Regenerative Medicine Market Forecast by Country, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 43 Translational Regenerative Medicine Market Forecast by Product, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 44 Translational Regenerative Medicine Market Forecast by Application, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 45 Japan Translational Regenerative Medicine Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 46 China Translational Regenerative Medicine Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 47 India Translational Regenerative Medicine Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 48 Australia Translational Regenerative Medicine Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 49 South Korea Translational Regenerative Medicine Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 50 Rest of Asia Pacific Translational Regenerative Medicine Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 51 Latin America Translational Regenerative Medicine Market Forecast by Country, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 52 Translational Regenerative Medicine Market Forecast by Product, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 53 Translational Regenerative Medicine Market Forecast by Application, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 54 Brazil Translational Regenerative Medicine Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 55 Mexico Translational Regenerative Medicine Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 56 Rest of Latin America Translational Regenerative Medicine Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 57 MEA Translational Regenerative Medicine Market Forecast by Country, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 58 Translational Regenerative Medicine Market Forecast by Product, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 59 Translational Regenerative Medicine Market Forecast by Application, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 60 GCC Translational Regenerative Medicine Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 61 South Africa Translational Regenerative Medicine Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 62 Rest of MEA Translational Regenerative Medicine Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 63 Strategic Outlook
Table 64 Amgen Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 65 Amgen Inc.: Product Benchmarking
Table 66 Amgen Inc. : Strategic Outlook
Table 67 Anterogen Co., Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 68 Anterogen Co., Ltd.: Product Benchmarking
Table 69 AVITA Medical, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 70 AVITA Medical, Inc.: Product Benchmarking
Table 71 AVITA Medical, Inc.: Strategic Outlook
Table 72 Biosolutions Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 73 Biosolutions Ltd.: Product Benchmarking
Table 74 Biosolutions Ltd.: Strategic Outlook
Table 75 bluebird bio, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 76 bluebird bio, Inc.: Product Benchmarking
Table 77 bluebird bio, Inc.: Strategic Outlook
Table 78 Bristol-Myers Squibb Company: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 79 Bristol-Myers Squibb Company: Product Benchmarking
Table 80 Bristol-Myers Squibb Company: Strategic Outlook
Table 81 Gilead Sciences, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 82 Gilead Sciences, Inc.: Product Benchmarking
Table 83 Gilead Sciences, Inc.: Strategic Outlook
Table 84 Integra LifeSciences: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 85 Integra LifeSciences: Product Benchmarking
Table 86 Integra LifeSciences: Strategic Outlook
Table 87 Mesoblast Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 88 Mesoblast Ltd.: Product Benchmarking
Table 89 Mesoblast Ltd.: Strategic Outlook
Table 90 Novartis AG: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 91 Novartis AG: Product Benchmarking
Table 92 Novartis AG: Strategic Outlook
Table 93 Organogenesis Inc.:(CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 94 Organogenesis Inc.: Product Benchmarking
Table 95 Organogenesis Inc.: Strategic Outlook
Table 96 Sarepta Therapeutics, Inc. :(CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 97 Sarepta Therapeutics, Inc.: Product Benchmarking
Table 98 Sarepta Therapeutics, Inc..: Strategic Outlook
Table 99 Smith+Nephew: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 100 Smith+Nephew: Product Benchmarking
Table 101 Smith+Nephew: Strategic Outlook
Table 102 TERUMO BCT, INC.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 103 TERUMO BCT, INC.: Product Benchmarking
Table 104 TERUMO BCT, INC.: Strategic Outlook
List of Figures
Figure 1 Translational Regenerative Medicine Market Segmentation
Figure 2 Translational Regenerative Medicine Market by Product: Market Attractiveness Index
Figure 3 Translational Regenerative Medicine Market by Application: Market Attractiveness Index
Figure 4 Translational Regenerative Medicine Market Attractiveness Index by Region
Figure 5 Translational Regenerative Medicine Market: Market Dynamics
Figure 6 Translational Regenerative Medicine Market by Region, 2024-2034 (US$ Billion, AGR %): “V” Shaped Recovery
Figure 7 Translational Regenerative Medicine Market by Region, 2024-2034 (US$ Billion, AGR %): “U” Shaped Recovery
Figure 8 Translational Regenerative Medicine Market by Region, 2024-2034 (US$ Billion, AGR %): “W” Shaped Recovery
Figure 9 Translational Regenerative Medicine Market by Region, 2024-2034 (US$ Billion, AGR %): “L” Shaped Recovery
Figure 10 Translational Regenerative Medicine Market: Porter’s Five Forces Analysis
Figure 11 Translational Regenerative Medicine Market: PEST Analysis
Figure 12 Translational Regenerative Medicine Market by Product: Market Attractiveness Index
Figure 13 Translational Regenerative Medicine Market Forecast by Product, 2024-2034 (US$ Billion, AGR %)
Figure 14 Translational Regenerative Medicine Market Share Forecast by Product, 2024 2029, 2034 (%)
Figure 15 Stem Cell Therapy Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 16 Stem Cell Therapy Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 17 Autologous Stem Cell Therapy Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 18 Autologous Stem Cell Therapy Market Share Forecast by Region, 2024 & 2034 (%)
Figure 19 Allogenic Stem Cell Therapy Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 20 Allogenic Stem Cell Therapy Market Share Forecast by Region, 2024 & 2034 (%)
Figure 21 Tissue Engineering Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 22 Tissue Engineering Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 23 Scaffold Tissue Engineering Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 24 Scaffold Tissue Engineering Market Share Forecast by Region, 2024 & 2034 (%)
Figure 25 Hydrogels Tissue Engineering Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 26 Hydrogels Tissue Engineering Market Share Forecast by Region, 2024 & 2034 (%)
Figure 27 Gene Therapy Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 28 Gene Therapy Market Share Forecast by Region, 2024 & 2034 (%)
Figure 29 Others Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 30 Others Market Share Forecast by Region, 2024 & 2034 (%)
Figure 31 Translational Regenerative Medicine Market by Application: Market Attractiveness Index
Figure 32 Translational Regenerative Medicine Market Forecast by Application, 2024-2034 (US$ Billion, AGR %)
Figure 33 Translational Regenerative Medicine Market Share Forecast by Application, 2024 2029, 2034 (%)
Figure 34 Oncology Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 35 Oncology Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 36 Dermatology Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 37 Dermatology Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 38 Musculoskeletal Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 39 Musculoskeletal Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 40 Neurology Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 41 Neurology Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 42 Cardiovascular Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 43 Cardiovascular Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 44 Wound Healing Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 45 Wound Healing Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 46 Ophthalmology Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 47 Ophthalmology Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 48 Others Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 49 Others Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 50 Translational Regenerative Medicine Market Forecast by Region 2023 and 2033 (Revenue, CAGR %)
Figure 51 Translational Regenerative Medicine Market Share Forecast by Region 2024 2029, 2034 (%)
Figure 52 Translational Regenerative Medicine Market by Region, 2024-2034 (US$ Billion, AGR %)
Figure 53 North America Translational Regenerative Medicine Market Attractiveness Index
Figure 54 North America Translational Regenerative Medicine Market by Region, 2024, 2029 & 2034 (US$ Billion)
Figure 55 North America Translational Regenerative Medicine Market Forecast by Country, 2024-2034 (US$ Billion, AGR %)
Figure 56 North America Translational Regenerative Medicine Market Share Forecast by Country, 2024 & 2034 (%)
Figure 57 North America Translational Regenerative Medicine Market Forecast by Product, 2024-2034 (US$ Billion, AGR %)
Figure 58 North America Translational Regenerative Medicine Market Share Forecast by Product, 2024 & 2034 (%)
Figure 59 North America Translational Regenerative Medicine Market Forecast by Application, 2024-2034 (US$ Billion, AGR %)
Figure 60 North America Translational Regenerative Medicine Market Share Forecast by Application, 2024 & 2034 (%)
Figure 61 U.S. Translational Regenerative Medicine Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 62 Canada Translational Regenerative Medicine Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 63 Europe Translational Regenerative Medicine Market Attractiveness Index
Figure 64 Europe Translational Regenerative Medicine Market by Region, 2024, 2029 & 2034 (US$ Billion)
Figure 65 Europe Translational Regenerative Medicine Market Forecast by Country, 2024-2034 (US$ Billion, AGR %)
Figure 66 Europe Translational Regenerative Medicine Market Share Forecast by Country, 2024 & 2034 (%)
Figure 67 Europe Translational Regenerative Medicine Market Forecast by Product, 2024-2034 (US$ Billion, AGR %)
Figure 68 Europe Translational Regenerative Medicine Market Share Forecast by Product, 2024 & 2034 (%)
Figure 69 Europe Translational Regenerative Medicine Market Forecast by Application, 2024-2034 (US$ Billion, AGR %)
Figure 70 Europe Translational Regenerative Medicine Market Share Forecast by Application, 2024 & 2034 (%)
Figure 71 Germany Translational Regenerative Medicine Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 72 France Translational Regenerative Medicine Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 73 UK Translational Regenerative Medicine Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 74 Italy Translational Regenerative Medicine Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 75 Spain Translational Regenerative Medicine Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 76 Russia Translational Regenerative Medicine Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 77 Rest of Europe Translational Regenerative Medicine Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 78 Asia Pacific Translational Regenerative Medicine Market Attractiveness Index
Figure 79 Asia Pacific Translational Regenerative Medicine Market by Region, 2024, 2029 & 2034 (US$ Billion)
Figure 80 Asia Pacific Translational Regenerative Medicine Market Forecast by Country, 2024-2034 (US$ Billion, AGR %)
Figure 81 Asia Pacific Translational Regenerative Medicine Market Share Forecast by Country, 2024 & 2034 (%)
Figure 82 Asia Pacific Translational Regenerative Medicine Market Forecast by Product, 2024-2034 (US$ Billion, AGR %)
Figure 83 Asia Pacific Translational Regenerative Medicine Market Share Forecast by Product, 2024 & 2034 (%)
Figure 84 Asia Pacific Translational Regenerative Medicine Market Forecast by Application, 2024-2034 (US$ Billion, AGR %)
Figure 85 Asia Pacific Translational Regenerative Medicine Market Share Forecast by Application, 2024 & 2034 (%)
Figure 86 Japan Translational Regenerative Medicine Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 87 China Translational Regenerative Medicine Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 88 India Translational Regenerative Medicine Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 89 Australia Translational Regenerative Medicine Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 90 South Korea Translational Regenerative Medicine Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 91 Rest of Asia Pacific Translational Regenerative Medicine Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 92 Latin America Translational Regenerative Medicine Market Attractiveness Index
Figure 93 Latin America Translational Regenerative Medicine Market by Region, 2024, 2029 & 2034 (US$ Billion)
Figure 94 Latin America Translational Regenerative Medicine Market Forecast by Country, 2024-2034 (US$ Billion, AGR %)
Figure 95 Latin America Translational Regenerative Medicine Market Share Forecast by Country, 2024 & 2034 (%)
Figure 96 Latin America Translational Regenerative Medicine Market Forecast by Product, 2024-2034 (US$ Billion, AGR %)
Figure 97 Latin America Translational Regenerative Medicine Market Share Forecast by Product, 2024 & 2034 (%)
Figure 98 Latin America Translational Regenerative Medicine Market Forecast by Application, 2024-2034 (US$ Billion, AGR %)
Figure 99 Latin America Translational Regenerative Medicine Market Share Forecast by Application, 2024 & 2034 (%)
Figure 100 Brazil Translational Regenerative Medicine Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 101 Mexico Translational Regenerative Medicine Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 102 Rest of Latin America Translational Regenerative Medicine Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 103 MEA Translational Regenerative Medicine Market Attractiveness Index
Figure 104 MEA Translational Regenerative Medicine Market by Region, 2024, 2029 & 2034 (US$ Billion)
Figure 105 MEA Translational Regenerative Medicine Market Forecast by Country, 2024-2034 (US$ Billion, AGR %)
Figure 106 MEA Translational Regenerative Medicine Market Share Forecast by Country, 2024 & 2034 (%)
Figure 107 MEA Translational Regenerative Medicine Market Forecast by Product, 2024-2034 (US$ Billion, AGR %)
Figure 108 MEA Translational Regenerative Medicine Market Share Forecast by Product, 2024 & 2034 (%)
Figure 109 MEA Translational Regenerative Medicine Market Forecast by Application, 2024-2034 (US$ Billion, AGR %)
Figure 110 MEA Translational Regenerative Medicine Market Share Forecast by Application, 2024 & 2034 (%)
Figure 111 GCC Translational Regenerative Medicine Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 112 South Africa Translational Regenerative Medicine Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 113 Rest of MEA Translational Regenerative Medicine Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 114 Translational Regenerative Medicine Market: Company Share, 2022
Figure 115 Amgen Inc.: Net Revenue, 2017-2022 (US$ Million, AGR %)
Figure 116 Amgen Inc.: R&D, 2017-2022 (US$ Million, AGR%)
Figure 117 Amgen Inc.: Regional Market Shares, 2022
Figure 118 AVITA Medical, Inc.: Net Revenue, 2017-2022 (US$ Million, AGR%)
Figure 119 AVITA Medical, Inc.: R&D, 2017-2022 (US$ Million, AGR %)
Figure 120 bluebird bio, Inc.: Net Revenue, 2017-2022 (US$ Million, AGR%)
Figure 121 bluebird bio, Inc.: R&D, 2017-2022 (US$ Million, AGR %)
Figure 122 Bristol-Myers Squibb Company: Net Revenue, 2017-2022 (US$ Million, AGR%)
Figure 123 Bristol-Myers Squibb Company: R&D, 2017-2022 (US$ Million, AGR%)
Figure 124 Bristol-Myers Squibb Company: Regional Market Shares, 2022
Figure 125 Gilead Sciences, Inc.: Net Revenue, 2017-2022 (US$ Million, AGR%)
Figure 126 Gilead Sciences, Inc.: R&D, 2017-2022 (US$ Million, AGR%)
Figure 127 Gilead Sciences, Inc.: Regional Market Shares, 2022
Figure 128 Integra LifeSciences: Net Revenue, 2017-2022 (US$ Million, AGR%)
Figure 129 Integra LifeSciences: R&D, 2017-2022 (US$ Million, AGR%)
Figure 130 Integra LifeSciences: Regional Market Shares, 2022
Figure 131 Mesoblast Ltd.: Net Revenue, 2017-2022 (US$ Million, AGR%)
Figure 132 Mesoblast Ltd.: R&D, 2017-2022 (US$ Million, AGR%)
Figure 133 Novartis AG: Net Revenue, 2017-2022 (US$ Million, AGR%)
Figure 134 Novartis AG: R&D, 2017-2022 (US$ Million, AGR%)
Figure 135 Novartis AG: Regional Market Shares, 2022
Figure 136 Organogenesis Inc.: Net Revenue, 2017-2022 (US$ million, AGR%)
Figure 137 Organogenesis Inc.: R&D, 2017-2022 (US$ million, AGR%)
Figure 138 Sarepta Therapeutics, Inc..: Net Revenue, 2017-2022 (US$ million, AGR%)
Figure 139 Sarepta Therapeutics, Inc.: R&D, 2017-2022 (US$ million, AGR%)
Figure 140 Smith+Nephew: Net Revenue, 2017-2022 (US$ million, AGR%)
Figure 141 Smith+Nephew: R&D, 2017-2022 (US$ million, AGR%)
Figure 142 Smith+Nephew: Regional Market Shares, 2022
Figure 143 TERUMO BCT, INC.: Net Revenue, 2017-2022 (US$ million, AGR%)
Figure 144 TERUMO BCT, INC.: Regional Market Shares, 2022
List of Companies Profiled in the Report
Amgen Inc.
Anterogen Co., Ltd.
AVITA Medical, Inc.
Biosolutions Ltd.
bluebird bio, Inc.
Bristol-Myers Squibb Company
Gilead Sciences, Inc.
Integra LifeSciences
Mesoblast Ltd.
Novartis AG
Organogenesis Inc.
Sarepta Therapeutics, Inc.
Smith+Nephew
TERUMO BCT, INC.
List of Other Companies Mentioned in the Report
3DBioFibR
AGC Biologics
Applied StemCell, Inc. (ASC)
Asklepios BioPharmaceutical
Aspen Neuroscience
Astellas Pharma Inc.
AstraZeneca
Bayer
Beacon Therapeutics Holdings Ltd
BioMarin Pharmaceutical
BlueRock Therapeutics
Canon
Cellectis
CoJourney Inc.
CRISPR Therapeutics
Crucible Therapeutics
FUJIFILM Diosynth Biotechnologies
JCR Pharmaceuticals Co., Ltd.
Krystal Biotech
MeiraGTx Holdings plc
OceanTech
Otsuka Pharmaceutical
Pantherna Therapeutics GmbH
QHP Capital
Regentis Biomaterials Ltd,
Sanofi
ShapeTX
Siren Biotechnology
SpliceBio
Syncona Ltd
Sysmex Corporation
Vertex Pharmaceuticals
List of Associations Mentioned in the Report
Alliance for Regenerative Medicine (ARM)
California Institute for Regenerative Medicine (CIRM)
European Association for the Study of the Liver (EASL)
Food and Drug Administration (FDA)
Fraunhofer Institute for Cell Therapy and Immunology (IZI)
French Ministry of Health
Indian Drugs Controller
International Liver Congress (ILC)
Japan Agency for Medical Research and Development (AMED)
National Institutes of Health (NIH)
National Science Foundation (NSF)
The University of Toronto
UK Regenerative Medicine Platform (UKRMP)
United Kingdom Medical Research Council (MRC)
Visiongain Pharma
Visiongain Pharma
Visiongain Pharma
